Significant improvements in reproductive and metabolic parameters, including reduced weight, BMI, and insulin levels, as well as better blood pressure and lipid profiles, demonstrate the potential of personalized interventions in managing PCOS-related risks. The gene discussed is INS; the disease is polycystic ovary syndrome.